Drawing for XAPIT

USPTO serial 77513248

XAPIT

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
SWAIN, MICHELE LYNN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with XAPIT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Tiffany Trunko

TIFFANY TRUNKO PFIZER INC.150 EAST 42ND STREET5TH FLOOR TRADEMARK DEPT.NEW YORK, NY 10017

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human useABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 12, 2010MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
Oct 11, 2010ABN5ABANDONMENT - AFTER PUBLICATION—
Oct 11, 2010EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Jun 11, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 10, 2010EX3GSOU EXTENSION 3 GRANTED—
Jun 9, 2010EXT3SOU EXTENSION 3 FILED—
Jun 9, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 6, 2010EX2GSOU EXTENSION 2 GRANTED—
Dec 18, 2009EXT2SOU EXTENSION 2 FILED—
Dec 18, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 22, 2009EX1GSOU EXTENSION 1 GRANTED—
Jun 22, 2009AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 1, 2009EXT1SOU EXTENSION 1 FILED—
Jun 1, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 23, 2008NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 30, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 10, 2008NPUBNOTICE OF PUBLICATION—
Aug 25, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 25, 2008ALIEASSIGNED TO LIE—
Aug 15, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 13, 2008DOCKASSIGNED TO EXAMINER—
Jul 7, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance